2018
DOI: 10.24193/subbchem.2018.4.08
|View full text |Cite
|
Sign up to set email alerts
|

"The effects of a new chromenyl-methylenethiazolidine-2,4-dione in alleviating oxidative stress in a rat model of streptozotocin induced diabetes "

Abstract: Type 1 diabetes mellitus (T1DM) is caused by the insulin deficiency resulting from the progressive destruction of pancreatic β cells. Thiazolidine-2,4-diones (TZDs) activate the peroxisome proliferator-activated receptor-γ (PPARγ) and enhance the actions of insulin. 5-((6-methyl-4-oxo-4Hchromen-3-yl)methylene)-3-(2-(4-nitrophenyl)-2-oxoethyl)-thiazolidine-2,4-dione (TZDd) is a heterocyclic derivative synthesized in our laboratory. The purpose of this study was to examine whether TZDd has hypoglycemic and antio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…The study of TZD hybrids from the point of view of their in silico design, chemical synthesis, investigation of their antitumor, antidiabetic, antiinflammatory, antioxidant and antimicrobial activities, has enabled the discovery of very promising and druglike candidates. Considering the aspects presented above and our previous experience in the synthesis of hybrid thiazolidine-2,4-dione derivatives and in the investigation of their antimicrobial [30,36], anti-inflammatory [38], antioxidant [18,31] and antitumour [37] potential, our aim in this work was to obtain new symmetric bis-thiazolidine-2,4-diones and to evaluate, in silico, their capacity to inhibit Raf and Ras oncoproteins, as potential antitumor drug candidates.…”
Section: Introductionmentioning
confidence: 99%
“…The study of TZD hybrids from the point of view of their in silico design, chemical synthesis, investigation of their antitumor, antidiabetic, antiinflammatory, antioxidant and antimicrobial activities, has enabled the discovery of very promising and druglike candidates. Considering the aspects presented above and our previous experience in the synthesis of hybrid thiazolidine-2,4-dione derivatives and in the investigation of their antimicrobial [30,36], anti-inflammatory [38], antioxidant [18,31] and antitumour [37] potential, our aim in this work was to obtain new symmetric bis-thiazolidine-2,4-diones and to evaluate, in silico, their capacity to inhibit Raf and Ras oncoproteins, as potential antitumor drug candidates.…”
Section: Introductionmentioning
confidence: 99%
“…The endothelial dysfunction (ED) that occurs in type 1 diabetes mellitus (T1DM) involves numerous and diverse pathogenetic mechanisms including inflammation, hyperglycaemia, production of reactive oxygen species (ROS) and of reactive nitrogen species (RNS), the decrease of nitric oxide (NO) availability or dyslipidemia [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 ]. Endothelial dysfunction is characterised by altered endothelial-dependent relaxation (EDR) produced by the decreased NO levels in the vessel wall [ 8 , 9 , 10 ], a process that leads to micro- and macrovascular complications, increasing significantly the morbidity and mortality in T1DM [ 1 ].…”
Section: Introductionmentioning
confidence: 99%